Endra Life Sciences Inc (NDRA)

Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	90.74% 2.7805	1.4578	3.1291	2.9946	2.9393
Depreciation and Amortization	30.10% 0.0153	0.0219	-	-	-
Operating Income/Loss	90.74% -2.7805	-1.4578	-3.1291	-2.9946	-2.9393
Income/Loss From Continuing Operations Before Tax	90.18% -2.7757	-1.4595	-3.1008	-2.5571	-2.9427
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	90.18% -2.7757	-1.4595	-3.1008	-2.5571	-2.9427
Net Income/Loss	290.18% 2.7757	-1.4595	-3.1008	-2.5571	-2.9427
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	5.5514	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-